KALA BIO Inc.

KALA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.55

+$0.01 (+2.04%)

At close: Sep 21, 2026, 3:59 PM ET

$0.57

+$0.02 (+3.64%)

Pre-market: Sep 22, 2026, 5:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	420K	2.1M	1.37M	1.86M	3.07M	3.05M	3.27M
Cost of Revenue	n/a	n/a	54K	n/a	n/a	n/a	69K	63K	61K	66K	70K	157K	77K	87K	-169K	180K	1.77M	775K	1.42M	908K	1.02M	1M
Gross Profit	n/a	n/a	-54K	n/a	n/a	n/a	-69K	-63K	-61K	-66K	-70K	-157K	-77K	-87K	169K	240K	326K	597K	438K	2.16M	2.04M	2.26M
Operating Income	-1.72M	-1.8M	-10.23M	-7.24M	-11.03M	-10.67M	-9.46M	-9.57M	-9.63M	-11.77M	-9.34M	-10.51M	-9.24M	-10.07M	-9.15M	-14.53M	-26.82M	-30.85M	-26M	-26.07M	-29.05M	-28.31M
Interest Income	140K	74K	n/a	270K	407K	463K	478K	570K	504K	504K	610K	708K	718K	675K	354K	234K	68K	8K	12K	16K	33K	43K
Pretax Income	-1.58M	-1.62M	686K	-7.56M	-11.16M	-8.95M	-8.18M	-8.95M	-9.58M	-11.81M	-8.63M	-8.7M	-10.41M	-14.46M	-12.84M	29.07M	-28.11M	-32.94M	-47.57M	-28.13M	-36.5M	-30.41M
Net Income	-1.58M	-1.62M	686K	-7.56M	-11.16M	-8.95M	-8.18M	-8.95M	-9.58M	-11.81M	-8.63M	-8.7M	-10.41M	-14.46M	-12.84M	29.07M	-28.11M	-32.94M	-47.57M	-28.13M	-36.5M	-30.41M
Selling & General & Admin	1.66M	1.74M	9.86M	4.53M	4.64M	4.59M	4.2M	4.4M	4.32M	5.36M	4.55M	4.8M	4.96M	5.94M	6M	9.38M	22.67M	26.98M	24.03M	25.35M	27.99M	27.7M
Research & Development	59K	61K	312K	6.13M	6.23M	6.06M	5.19M	5.11M	5.26M	6.35M	4.72M	5.55M	4.2M	4.04M	3.32M	5.39M	4.47M	4.47M	2.41M	2.88M	3.09M	2.88M
Other Expenses	n/a	n/a	n/a	-3.42M	153K	21K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.72M	1.8M	10.17M	7.24M	11.03M	10.67M	9.39M	9.51M	9.57M	11.71M	9.27M	10.35M	9.16M	9.98M	9.32M	14.77M	27.15M	31.45M	26.44M	28.23M	31.08M	30.58M
Interest Expense	n/a	n/a	141K	963K	1.08M	1.09M	1.39M	1.48M	1.46M	1.46M	1.47M	1.46M	1.41M	1.47M	1.58M	1.45M	2.21M	2.04M	2.08M	2.07M	2.09M	2.14M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.72M	1.8M	10.23M	7.24M	11.03M	10.67M	9.46M	9.57M	9.63M	11.77M	9.34M	10.51M	9.24M	10.07M	9.15M	14.95M	28.92M	32.22M	27.86M	29.14M	32.1M	31.58M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	74.16M	8.15M	8.15M	7.04M	6.51M	6.35M	4.69M	4.63M	3.03M	2.81M	2.71M	2.55M	2.39M	2.07M	1.52M	1.5M	1.47M	1.47M	1.3M	1.3M	1.29M	1.23M
Shares Outstanding (Diluted)	74.16M	8.15M	8.15M	7.04M	6.51M	6.35M	4.69M	4.63M	3.03M	2.81M	2.71M	2.55M	2.39M	2.07M	1.52M	1.51M	1.47M	1.47M	1.3M	1.31M	1.29M	1.23M
EPS (Basic)	-21.32	-0.20	0.08	-1.07	-1.71	-1.41	-1.74	-1.93	-3.16	-4.20	-3.18	-3.41	-4.36	-6.99	-7.96	19.39	-18.50	-22.41	-36.56	-21.62	-28.27	-24.66
EPS (Diluted)	-21.32	-0.20	0.08	-1.07	-1.71	-1.41	-1.74	-1.93	-3.16	-4.20	-3.18	-3.41	-4.36	-6.99	-7.82	19.25	-18.50	-22.41	-36.56	-21.41	-28.27	-24.66
EBITDA	-1.72M	-1.62M	881K	-6.47M	-10.01M	-7.79M	-6.71M	-7.41M	-8.06M	-10.29M	-7.09M	-7.09M	-8.92M	-12.89M	-11.19M	30.69M	-25.53M	-30.57M	-45.28M	-25.2M	-33.56M	-28.02M
EBIT	-1.72M	-1.62M	827K	-6.6M	-10.07M	-7.86M	-6.78M	-7.47M	-8.12M	-10.35M	-7.16M	-7.25M	-9M	-12.98M	-11.27M	30.52M	-25.9M	-30.91M	-45.49M	-26.06M	-34.41M	-28.27M
Depreciation & Amortization	n/a	n/a	54K	128K	67K	68K	69K	63K	61K	66K	70K	157K	77K	87K	80K	169K	371K	338K	212K	852K	845K	248K